JDD in the Media

Could You Be Allergic to Additives?

By December 30, 2019February 14th, 2020No Comments
A recent article from US News, “Could You Be Allergic to Additives?” cites a January 2013  JDD study  on whether common additives in food or medications can cause reactions in some people.
The study, “Medication Dyes as a Source of Drug Allergy,” states “Excipients are defined as inert substances added to a drug or food to confer a suitable consistency, appearance, or form. They may be added for bulk, to change dissolution or the kinetics of absorption, to improve stability, to influence palatability, or to create a distinctive appearance. The last function may depend heavily on the use of coloring agents, especially when there are multiple dosages (such as with warfarin), and dose confusion may result in profound complications. While described as inert, excipients have been associated with triggering immunological reactions, although this is almost never considered in common practice when patients have reactions to medications, even when they appear to react to many different and distinct drugs.”
Read Article Now

You May Also Like

AcneDerm CommunityFeatured ArticlesJDD HighlightsJDD in the MediaThe Latest
May 21, 2025

JDD in the News: Upadacitinib’s Potential Cardiovascular Effects 

Upadacitinib may provide additional health benefits, including reducing the risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). That’s according to a May Journal of Drugs in Dermatology…
JDD HighlightsJDD in the MediaThe Latest
May 20, 2025

Dermatology Roundup: Survey Shows Misconceptions About Sunscreen and Skin Aging

By Allison Sit A new American Academy of Dermatology (AAD) survey shows American adults may not fully understand the benefits of sunscreen. The survey of 1,000 adults found nearly one…
JDD HighlightsJDD in the MediaThe Latest
April 16, 2025

Dermatology Roundup: Dermatologist Joins Investigators at Chan Zuckerberg Biohub New York

By Allison Sit Dermatologist Aimee Payne, MD, PhD, is part of the second cohort of investigators with the Chan Zuckerberg Biohub New York, a research institute that is focused on harnessing…

Leave a Reply